Clinical Trial Update: To Investigate the Safety and Efficacy of UB-421 Monotherapy in HIV Infected Adults [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial evaluating UB-421 as monotherapy in HIV-infected adults; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• UB-421 (anti-CD4 antibody)

Snippet

Sponsor: United BioPharma | Conditions: HIV-1 Infection | Phase 2 | Status: COMPLETED